College of Pharmacy Home | URI Home | e-Campus | Webmail | Fast Links | Directories | Search

University of Rhode Island College of Pharmacy
    College of Pharmacy > Department of Biomedical and Pharmaceutical Sciences > Faculty and Staff

 

Fatemeh Akhlaghi, Pharm. D., Ph.D.
Associate Professor of Pharmacokinetics
fatemeh@uri.edu

Click here for information about Dr. Akhlaghi's lab

Education:

  • Ph.D., University of Sydney, Australia, 1996
  • Pharm.D., University of Mashhad, Iran, 1990

Experience:

  • Associate Professor with Tenure, College of Pharmacy, University of Rhode Island, USA; 2006-current
  • Assistant Professor, College of Pharmacy, University of Rhode Island, USA; 2001-2005
  • Senior Clinical Scientist, Pharmacology Clinical Research Unit, Addenbrooke's and Papworth Hospitals, University of Cambridge, United Kingdom; 1998-2000
  • Postdoctoral Research Associate, Faculty of Pharmacy, University of Sydney, Australia; 1996-1998

Research Interests:

  • Immunosuppressive agents PK/PD following organ transplantation
  • Therapeutic drug monitoring
  • Drug disposition and effect in diabetes mellitus

Publications:

Rosenbaum SE, Baheti G, Trull AK, Akhlaghi F. Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients. Ther Drug Monit 2005; 27:116-122.

Soman RS, Zahir H, Akhlaghi F. Development and validation of an HPLC-UV method for determination of iohexol in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 816:339-343.

Zahir H, McLachlan AJ, Nelson A, McCaughan G, Gleeson M, Akhlaghi F. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients. Ther Drug Monit 2005; 27:422-430.

Akhlaghi F, Gonzalez L, Trull AK. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients. J Heart Lung Transplant 2005; 24:2120-2128.

Akhlaghi F, Patel CG, Zuniga XP, Halilovic J, Preis IS, Gohh RY. Pharmacokinetics of mycophenolic acid and metabolites in diabetic kidney transplant recipients. Ther Drug Monit 2006; 28:95-101.

Mendonza AE, Gohh RY, Akhlaghi F. Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry. Ther Drug Monit 2006; 28:402-406.

Shi D, Yang J, Yang D, LeCluyse EL, Black C, You L, Akhlaghi, F, Yan B. Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther 2006; 319:1477-1484.

Zahir H, Keogh A, Akhlaghi F. Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipids. Ther Drug Monit 2006; 28:818-826.

Mendonza AE, Zahir H, Gohh RY, Akhlaghi F. Tacrolimus in diabetic kidney transplant recipients: pharmacokinetics and application of a limited sampling strategy. Ther Drug Monit 2007; 29:391-398.

Patel CG, Richman K, Yang D, Yan B, Gohh RY, Akhlaghi F. Effect of diabetes on mycophenolic acid concentration and inosine monophosphate dehydrogenase activity in kidney transplant recipients. Ther Drug Monit 2007; 29:735-742.

 


URILogo-sm.gif (417 bytes)

© University
of Rhode Island
Disclaimer

For more information, contact:
College of Pharmacy

Fogarty Hall, 41 Lower College Road, Kingston, RI 02881

Phone: 401-874-5842, Fax: 401-874-2181
E-mail: pharmcol@etal.uri.edu.

The University is an affirmative action/equal opportunity employer.
All rights reserved